IL-4i1 Regulation of Immune Protection During Mycobacterium tuberculosis Infection

Abstract

Background Interleukin-4-induced gene 1 (IL-4i1) encodes L-phenylalanine oxidase that catabolizes phenylalanine into phenylpyruvate. IL-4i1 is mainly expressed by antigen-presenting cells, inhibits T-cell proliferation, regulates B-cell activation, drives macrophage polarization and modulates Th1 inflammatory immune responses, but its role in bacterial infections is understudied. Methods Herein, we evaluated IL-4i1 deletion in macrophages and mice upon infection with virulent H37Rv and W-Beijing lineage hypervirulent HN878 Mycobacterium tuberculosis (Mtb) strains. The bacterial growth and pro-inflammatory responses were measured in vitro and in vivo. Histopathological analysis, lung immune cell recruitment and macrophage activation were assessed at the early and chronic stages of Mtb infection. Results IL-4i1 -/- mice displayed increased protection against acute H37Rv and HN878 and chronic HN878 Mtb infections; with reduced lung bacterial burdens and altered antigen-presenting cell (APC) responses when compared to wild-type mice. Moreover, “M1-like” interstitial macrophage numbers, nitrite and interferon production were significantly increased in IL-4i1 -/- mice when compared to wild-type mice during acute Mtb HN878 infection. Conclusions Together, these data suggest that IL-4i1 regulates APC-mediated inflammatory responses during acute and chronic Mtb infection. Hence IL-4i1 targeting has the potential as an immunomodulatory target for host-directed therapy.

New insight into arginine and tryptophan metabolism in macrophage activation during tuberculosis

“…These mice exhibited reduced lung bacterial burdens and alterations in APC responses ( 107 ). In addition, during acute MTB HN878 infection, IL-4I1 -/- mice exhibited a significant increase in the numbers of “M1-like” interstitial macrophages, as well as higher NO and IFN-γ production when compared to wild-type mice ( 108 ). It is possible that the simultaneous deletion of both IL4i1 and IDO1, despite their overlapping expression patterns in myeloid cells, may be necessary to disrupt the three primary biochemical outcomes: tryptophan depletion, AHR activation, and ferroptosis suppression ( 102 , 109 ).…”

IL4I1 in head and neck squamous cell carcinoma: A potential therapeutic target associated with immune infiltration

“…Recent studies have reported the immunogenic role of IPS in predicting immunotherapy response 20,17 . We used the IPS le downloaded from TCIA to determine whether IL4I1 expression could predict immunotherapy response in patients with HNSCC.…”